GSK plc Share Buyback Transaction - March 31, 2026

GSK plc filed a Form 6-K reporting a share buyback transaction conducted on March 31, 2026. The company purchased 340,000 of its own ordinary shares through BNP Paribas SA as part of its existing buyback program announced on February 17, 2026. The shares were acquired at prices ranging from 2,064.00p to 2,086.00p per share, with a volume-weighted average price of 2,075.26p. The purchased shares will be held as treasury shares. Following this transaction, the company now holds 256,112,615 ordinary shares in treasury and has 4,060,067,166 ordinary shares in issue (excluding treasury shares). The total number of voting rights remains 4,060,067,166, with treasury shares representing 6.31% of voting rights. The filing provides detailed transaction data across three trading venues: BATE (47,202 shares), CHIX (69,556 shares), and XLON (223,242 shares), with individual transaction records showing the timing and pricing of each trade throughout the trading day.